Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

A new method reliably detects minoxidil in hair products, revealing some non-compliance with regulations.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

A new method accurately measures DHEAS in blood, improving on current tests.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

The compound 4c effectively inhibits the enzyme linked to hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

CyRL-QN15 peptide boosts hair growth in diabetic mice by activating specific cell pathways.

5-ARI therapy may help prevent prostate cancer progression.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Ruxolitinib can cause a delayed skin reaction on the nose.

The research helps understand how finasteride works and aids drug development.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Isoliensinine, a natural compound, prevents stress-related hair greying by blocking a specific receptor on hair cells.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Minoxidil reacts to nitrosation 7 times more than phenol, mainly due to its -NH₂ groups, leading to the creation of N-nitrosominoxidil.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.